The cannabinoid 1 receptor antagonist AM251 produces nocifensive behavior via activation of ERK signaling pathway

Neuropharmacology
Soh KatsuyamaT Sakurada

Abstract

Intrathecal (i.t.) injection of AM251, a cannabinoid 1 (CB(1)) receptor antagonist, into the spinal lumbar space of mice elicited a behavioral response consisting of biting and licking with a few scratchings. In this study, we investigated to determine whether i.t. AM251 could influence the activity of extracellular signal-regulated kinase-1 and -2 (ERK1/2), a mitogen-activated protein kinase (MAPK) in neuronal nitric oxide synthase (nNOS) and inducible NOS (iNOS) activation. The CB(1) receptor agonist ACEA, neurokinin 1 (NK(1)) receptor antagonists and NMDA receptor antagonists, inhibited i.t. AM251-induced behavioral response in a dose-dependent manner. The CB(2) receptor agonist, JWH-133 gave no effect on response elicited by i.t. AM251. Both non-selective NOS inhibitors, L-NAME and 7-NI, and N(ω)-propyl-L-arginine, a selective inhibitor of nNOS resulted in a dose-dependent inhibition of i.t. AM251-induced behavioral response. The selective iNOS inhibitor, 1400W, in relatively large doses, inhibited in a non dose-dependent manner. The i.t. injection of AM251 produced a definite activation of ERK1/2 in the lumbar dorsal spinal cord. Behavioral experiments showed that U0126, a MAPK/ERK kinase (MEK) inhibitor, dose-dependently ...Continue Reading

References

Dec 14, 1992·Neuroscience Letters·K F KittoG L Wilcox
Oct 17, 1980·European Journal of Pharmacology·J L Hylden, G L Wilcox
Feb 21, 1994·Brain Research·P LiJ P Figueroa
Mar 14, 1995·European Journal of Pharmacology·Y KuraishiM Satoh
Feb 1, 1993·Pain·S T Meller, G F Gebhart
Jun 1, 1996·Journal of the Neurological Sciences·Y ChoiJ R Tobin
May 31, 2003·Canadian Journal of Physiology and Pharmacology·Clemente VásquezLeonardo Hernández
Jul 28, 2005·The European Journal of Neuroscience·Devi Rani SagarVictoria Chapman
Jan 20, 2007·The AAPS Journal·Andrea G Hohmann, Richard L Suplita
Jan 17, 2009·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·C D MunhozJ C Leza

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.